Wakayama Medical University Researchers Provide New Insights into Kinase Inhibitors (Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced NSCLC-A Brief Report From the CROWN Study)

Source :: Obesity, Fitness & Wellness Week. March 16, 2024, 6467
Publication Year :: 2024
Abstract: 2024 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on kinase inhibitors. According to news originating from [...]

Subjects :: Pfizer Inc. -- Reports
Lung cancer, Non-small cell -- Research
Crizotinib -- Research
Physical fitness -- Research -- Reports
Pharmaceutical industry -- Reports -- Research
Health

Tools